Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2019 Jan 21;234(8):13807–13819. doi: 10.1002/jcp.28061

RETRACTED: Circular RNA circ_0001946 acts as a competing endogenous RNA to inhibit glioblastoma progression by modulating miR‐671‐5p and CDR1

Xinxing Li 1, Hongyu Diao 1,✉
PMCID: PMC13483025  PMID: 30663767

Abstract

Objectives

In many malignant tumors, circRNAs play an important role. However, the biological role and clinical significance of circRNAs remain unclear. In this study, we investigated the effects of circ_0001946 on the progression of glioblastoma (GBM) and the molecular mechanism of circ_0001946.

Methods

Microarrays were applied to test the expression profiles of circRNAs and messenger RNAs (mRNAs). Coexpressed genes were identified by constructing differentially expressed circRNA–mRNA networks. The expression of circ_0001946, miR‐671‐5p, and cerebellar degeneration‐related autoantigen 1 (CDR1) was detected by real‐time quantitative PCR, and the protein expression of CDR1 was determined by western blotting. A dual‐luciferase reporter assay was used to evaluate potential miR‐671‐5p target sites on circ_0001946 and CDR1. The proliferation, apoptosis, migration, and invasion of GBM cells were assessed by a colony formation assay, flow cytometry assay, transwell migration assay, and transwell invasion assay. Xenograft mouse models were used to determine the role of circ_0001946 in vivo.

Results

The expression of circ_0001946 and CDR1 was low and that of miR‐671‐5p was high in GBM cells. Circ_0001946 suppressed the expression of miR‐671‐5p, thus upregulating the expression of CDR1, the gene downstream of miR‐671‐5p. Circ_0001946 and CDR1 reduced proliferation, migration, and invasion and increased apoptosis in GBM cells, whereas miR‐671‐5p had an opposite effect. The xenograft mouse model and immunohistochemistry results indicated that circ_0001946 inhibited GBM growth as well as the expression of Ki67 in GBM cells.

Conclusion

Our study confirmed that the circ_0001946/miR‐671‐5p/ CDR1 pathway modulates the development of GBM, and this pathway might be a promising target for the development of therapeutics for GBM.

Keywords: cerebellar degeneration‐related autoantigen 1 (CDR1), circ_0001946, glioblastoma, miR‐671‐5p, proliferation


The results of our study demonstrated that circ_0001946 could sponge miR‐671‐5p and restrain glioblastoma (GBM) cell malignancy. The activation of the circ_0001946/miR‐671‐5p/cerebellar degeneration‐related autoantigen 1 (CDR1) axis may be a potential therapeutic target and contribute to the treatment of human GBM.

graphic file with name JCP-234-13807-g004.jpg

1. INTRODUCTION

Glioma, the most common type of lethal primary brain tumor, can be classified into four grades, WHO I to IV, according to the WHO 2007 criteria. Belonging to WHO Grade IV, glioblastoma multiforme (GBM) is the most aggressive form, with rapid recurrence and uniformly poor prognosis (Zhu et al., 2017). The average lifespan of patients with GBM after diagnosis is only 15 months, despite treatments combining surgery, chemotherapy, and radiotherapy (Wang et al., 2015). Because of the location, aggressive biological behavior, and diffuse infiltrative growth of the tumor, GBM remains a difficult cancer to treat, although therapeutic options have been improving (Omuro & DeAngelis, 2013). In addition, a lack of knowledge about the pathogenesis of GBM is one of the causes of low survival rates (Maachani, Tandle, Shankavaram, Kramp, & Camphausen, 2016). Therefore, it is of great importance to further study the molecular mechanisms underlying GBM progression, and thus determine new therapeutic targets and treatment strategies.

microRNAs (miRNAs), a class of small noncoding RNAs, can negatively regulate gene expression by directly binding to complementary sequences in the 3′‐untranslated region (3′‐UTR) of a target messenger RNA (mRNA). Some miRNAs act as tumor suppressors and some as oncogenes; the effect of a miRNA depends on the functions of the target genes (Chung et al., 2015). It has been reported that miR‐671‐5p can directly target FOXM1 to suppress breast cancer, indicating that miR‐671‐5p may be a potential target for breast cancer management (Tan et al., 2016). Another report showed that miR‐671‐5p distinctly decreased both the mRNA and protein levels of SMARCB1, suggesting that miR‐671‐5p might be a vital part of oncogenesis in epithelioid sarcoma (Papp, Krausz, Stricker, Szendroi, & Sapi, 2014). In addition, the downregulation of miR‐671‐5p expression enhanced the immunomodulatory ability of orbital fat‐derived stem cells, whose paracrine effect could inhibit the proinflammatory functions and proliferation of macrophages (Lien et al., 2014). Therefore, miR‐671‐5p is a factor worthy of being studied in cancers.

Circular RNAs (circRNAs), a group of non‐protein‐coding RNAs with structures that are covalently closed loops with no 5′ to 3′ polarity, were validated to have a widespread distribution and a substantial presence throughout the eukaryotic transcriptome (Zhu et al., 2017). Recently, researchers have found a large number of endogenous circRNAs in mammalian cells; some of the circRNAs are highly abundant and evolutionarily conserved (Jeck & Sharpless, 2014). The abundance, diversity, and conservation of circRNAs suggest that these RNA molecules might have some biological functions, such as miRNA activity modulation, alternative splicing regulation, or “sponging” RNA‐binding proteins or RNA protein complexes (RNPs) (Lasda & Parker, 2014). Importantly, circRNAs have been identified as “miRNA sponges,” functioning as miRNA inhibitors, with a single circRNA targeting multiple miRNAs (Yang et al., 2018). Thus, the study of circRNAs presents huge potential therapeutic implications and research applications.

Cerebellar degeneration‐related autoantigen 1 (CDR1) is a highly conserved neuroectodermal marker mapping to chromosome X in humans and mice. CDR1 mRNA is detected in abundant amounts in the human brain, particularly in the cerebellum, and in small amounts in other normal tissues. CDR1 expression has also been detected in cell lines derived from neuroectodermal cancers, such as astrocytoma, melanoma, and neuroblastoma (Chen et al., 1990). The CDR1 gene is located in the region Xq27.1, which is characterized by a high density of large segmental duplications (SDs; Chen et al., 1990). Accordingly, CDR1 contains a tandem hexapeptide repeat structure, contributing to its high immunogenicity, and the autoimmune responses in the patients with paraneoplastic cerebellar degeneration interrupt some of the functions important for the survival of Purkinje cells (Satoh & Yamamura, 2004).

In the present study, we screened differentially expressed mRNAs and circRNAs in GBM as well as the miRNAs that interact with them. CDR1 and circ_0001946 were determined to be differentially expressed in GBM cell lines, and miR‐671‐5p was found to be simultaneously targeted by CDR1 and circ_0001946. CircRNA–miRNA–mRNA interaction networks might be involved and play a vital role in tumor development, and here we aimed to study how hsa_circ_0001946 could play a role in GBM by evaluating the correlations between circ_0001946, miR‐671‐5p, and CDR1 to further explore pathogenesis and a potential therapy in GBM.

2. MATERIALS AND METHODS

2.1. Gene expression profiles

The high‐throughput sequencing data for three paired glioma tissue and normal brain tissue samples were downloaded from the Gene Expression Omnibus database, a publicly available database. The series accession number was GSE86202, and the platform was GPL16791. In the analysis, we used three kinds of blob selector including HTSeq, FindCirc, and CIRC_FINDER. Among them, HTSeq was used to identify mRNAs, and FindCirc and CIRC_FINDER were used for circRNAs. By means of next‐generation sequencing, the presence and quantity of RNA in a biological sample at a given moment in time were ascertained with RNA‐seq, averting many limitations of other transcriptomic approaches. Data quality control was assessed with FastQC. The GENCODEv.19 Gene Transfer format file was used as a transcript reference (GENCODE annotation). We used RNA‐seq to match the sequencing data to the genome and then extracted the fragments for undirected comparison, followed by recombination and comparison with the genome.

2.2. Differential expression analysis

The statistical software R and Bioconductor package DESeq. 2 were applied to screen differentially expressed mRNAs and circRNAs. MRNAs with differential expression were selected with the threshold set to |log2FC| > 2 (fold change [FC]) and an adjusted p < 0.01. The p value was adjusted by the Benjamini‐Hochberg procedure. Differentially expressed circRNAs were screened under the parameters |log2FC| > 2 and p < 0.05. Though an intersection analysis (Venn diagram), 22 common circRNAs with differential expression, including circ_0001946, were identified in the glioma tumor tissue.

CircNet (http://circnet.mbc.nctu.edu.tw/) was used to detect miRNA sponges and to filter a gene or miRNA of interest to establish the associated gene–miRNA–circRNA regulatory network. CircInteractome (https://circinteractome.nia.nih.gov/) was used to identify potential miRNA binding sites on circRNAs.

2.3. Glioma cell line culture and transfection

Glioma cell lines (U87 and U251 cells) and human microglia (HM) were purchased from the American Type Culture Collection (Washington, DC) and maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 50 U/ml penicillin G, and 250 µg/ml streptomycin at 37°C in a humidified environment with 5% CO2.

miR‐671‐5p mimics/inhibitor and the corresponding negative control were purchased from GenePharma (Shanghai, China). Short interfering RNAs (siRNAs) for knocking out circ_0001946 (circ_CDR1) were designed on the Thermo Fisher Scientific website and synthesized by Sangon Biotech (Shanghai, China). pcDNA3.1 (Cyagen, SuZhou, China) was used to overexpress circ_0001946 and CDR1. Transfections were performed in serum‐free medium 24 hr after plating with Lipofectamine 2000 (Invitrogen). After 6 hr, the transfected cells were placed in complete medium and maintained at 37°C in 5% CO2. The siRNA sequences used are listed below:

si‐circ_0001946‐1: 5′‐GCAATATCCAGGGTTTCCGAT‐3′;

si‐circ_0001946‐2: 5′‐TGCAATATCCAGGGTTTCCGA‐3′; and

si‐circ_0001946‐3: 5′‐TGTCTGCAATATCCAGGGTTT‐3′.

2.4. Quantitative real‐time PCR

Total RNA was obtained from cultured cells using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. To detect the circ_0001946 and miR‐671‐5p levels, quantitative real‐time PCR (qRT‐PCR) was performed using SYBR Premix DimerEraser (Takara) with a 7900HT system. GAPDH/U6 were used as internal controls. FCs were calculated by the relative quantification method (2−ΔΔCt ). The primers sequences of the evaluated genes are listed in Table 1.

Table 1.

Primers used for PCR validation

Gene Forward and reverse primers
Circ_0001946 F: 5′ CCAACGTCTCCAGTGTGCTG 3′
miR‐671‐5P R: 5′ AGTTGTTGGAAGACCTTGACAC 5′
F: 5′ ACCTAACACTAAGGATCACGGA 3′
R: 5′ CATCCACACCAAAGGGGGAA 3′
GAPDH F: 5′ CATGAGAAGTATGACAACAGCCT 3′
U6 R: 5′ AGTCCTTCCACGATACCAAAGT 3′
F: 5′ CTCGCTTCGGCAGCACA 3′
R: 5′ AACGCTTCACGAATTTGCGT 3′

2.5. Dual‐luciferase reporter assay

The targeting site was predicted by TargetScan (http://www.targetscan.org/vert_71/). Dual‐luciferase reporter plasmids were constructed using pmirGLO dual‐luciferase vectors (GenePharma). The sequences of miR‐671‐5p, circ_0001946, and CDR1 were cloned into the vectors separately. Lipofectamine 2000 (Invitrogen) was used to cotransfect GBM cells with circ_0001946‐wt/circ_0001946‐mut or CDR1‐wt/CDR1‐mut together with the miR‐671‐5p mimics/negative control. After a 48 hr induction, luciferase activity was assessed using a dual‐luciferase reporter kit (Promega, Madison, WI). The normalization of the relative firefly luciferase activity was carried out using the Renilla luciferase activity as a reference. The sequences were synthesized by Sangon Biotech.

2.6. Western blot analysis

Cells were washed three times with prechilled phosphate‐buffered saline (PBS). The cells were lysed in radio‐immunoprecipitation assay (RIPA) lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X‐100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate [SDS], 1 mM phenylmethanesulfonyl fluoride (PMSF), and a protease inhibitor mixture). The total protein lysates were separated by SDS‐polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes. The membranes were blocked with skim milk for 1 hr at room temperature, and then the blot was incubated with primary antibodies recognizing rabbit CDR1 (PA5‐68142, 1:1,000) and GAPDH (ab9485, 1:2,500) at 4°C overnight. After washing with tris‐buffered saline tween (TBST) buffer three times, the blot was then incubated with a secondary goat anti‐rabbit IgG antibody (ab6721, 1:10,000) conjugated with horseradish peroxidase. Finally, the protein was detected using a super signal protein detection kit (Pierce). Both the anti‐GAPDH and goat anti‐rabbit IgG antibodies were purchased from Abcam (Cambridge, MA). The anti‐CDR1 antibody was obtained from Thermo Fisher Scientific (Cambridge, MA).

2.7. Transwell assay

Cell suspensions (5 × 105 cells/ml) were prepared with serum‐free medium. For the transwell migration assays, 100 μl cell suspension (5 × 104 cells) and 200 μl serum‐free medium was added in the top chamber of a 24‐well cell invasion assay plate (Costar) containing a polycarbonate transwell filter without Matrigel. A total of 500 μl chemokine was placed in the lower chamber. For the invasion assays, the polycarbonate filter was coated with Matrigel, and the other experimental procedures were analogous to those of the migration assays. The cells were cultured at 37°C for 8 hr for the migration assays or 36 hr for the invasion assays. The cells in the top chamber were then removed with cotton swabs. Then cells that migrated and invaded the lower membrane surface were washed twice with PBS and fixed in 4% paraformaldehyde for 30 min. The cells were washed again using PBS, and 0.1% crystal violet was used to stain the cells for 20 min. After the cells were washed at least three times with double‐distilled H2O, the membrane was dried and subsequently observed using a light microscope. The assays were performed in triplicate, and the data are presented as the mean ± standard error.

2.8. Colony formation assays

Cells were harvested, seeded in 6‐well plates and incubated at 37°C, and the medium was replaced every 3 days. After incubating for 7–10 days, the cells were washed twice with PBS, fixed with 95% ethanol for 10 min, stained with 0.1% crystal violet for 10 min, and subsequently washed with PBS three times. The number of visible colonies was counted, and the representative colonies were captured for each well. Each experiment was performed in triplicate.

2.9. Flow cytometry analysis

The U87 and U251 cell lines were first digested and stained with an Annexin V‐FITC/propidium iodide (PI) Apoptosis Detection kit (Biouniquer Technology, Nanjing, China) according to the instructions of the manufacturer. The cell concentration then reached a density of 1 × 105. Then, 100 μl suspension was incubated with annexin V‐FITC and PI at room temperature for 10 min. A flow cytometer (BD Pharmingen, San Diego, CA) was used to detect cell apoptosis.

2.10. Xenograft mouse models

All mouse experiments were approved by Shengjing Hospital of China Medical University. All animals used were 6‐week‐old female BALB/c nude mice (Animal Research Centre, Perth, Australia). A subcutaneous xenograft model was established by injecting 5 × 106 U87 cells transfected with empty vector (control), si‐circ_0001946, circ_0001946, circ_0001946+miR‐671‐5p, or circ_0001946+CDR1 subcutaneously into the hip area on both sides of the nude mice. After 5 weeks, the mice were killed, and the subcutaneous xenograft tumors were isolated. The tumors were extracted and stored at −80°C. Tumor volume was calculated by using the equation: volume (mm3) = A × B 2/2, where A is the largest diameter, and B is the diameter perpendicular to A.

2.11. Immunohistochemical staining

For immunohistochemical analysis, tissue sections were deparaffinized, rehydrated and subjected to high‐temperature antigen retrieval in 10 mM citrate buffer (pH 6.0). An anti‐Ki67 antibody (ab15580, 1:2,000; Abcam) was applied for 2 hr in blocking buffer (2.5% bovine serum albumin (BSA), 5% goat serum, and 0.3% Triton X‐100 in PBS), followed by species‐appropriate secondary Alexa Fluor 488 dye‐conjugated antibodies (Amersham). Fluorescent antibody‐labeled slides were mounted in DAKO fluorescent mounting medium containing 1 μg/ml Hoechst counterstain. Horseradish peroxidase (HRP)‐conjugated secondary antibodies were visualized by diaminobezidin (DAB) staining (Vector Laboratories). Apoptotic cells were detected with an ApopTag Detection kit (Chemicon International). Images were obtained with an Axiovert S100 TV inverted fluorescence microscope (Zeiss) and Open Lab 3.5.1 software or with an Axiovert 100 inverted microscope (Zeiss) equipped with a Hamamatsu Orca digital camera.

2.12. Statistical analysis

Statistical analysis was carried out using GraphPad Prism 6.0 (GraphPad Software, Inc., San Diego, CA), and the results are presented as the mean ± standard deviation. To determine statistical significance, Student's t test and one‐way analysis of variance were performed for comparisons of two or more groups. When the p value was less than 0.05, the difference was considered statistically significant.

3. RESULTS

3.1. CDR1 and circ_0001946 levels were both downregulated in GBM

RNA‐seq was performed to detect mRNAs and circRNAs. A total of 23,000 mRNAs were identified by HTSeq, 493 and 254 circRNAs were identified by FindCirc and CIRC_FINDER, respectively. Then, DESeq. 2 was used to identify differentially expressed mRNAs (log2FC > 2, adjusted P < 0.01) and circRNAs (log2FC > 2, p < 0.05). In total, 2,437 mRNAs were differentially expressed in GBM, 85 differentially expressed circRNAs were detected in the FindCirc group, and 41 differentially expressed circRNAs were detected in the CIRC_FINDER group. Figure 1a,b shows the top 20 differentially expressed mRNAs and circRNAs (CIRC_FINDER group), respectively.

Figure 1.

Figure 1

Function annotations for deregulated genes in GBM. (a) The top 10 mRNAs with the most upregulated and downregulated expression in glioma. (b) The top 10 circRNAs with the most upregulated and downregulated expression in glioma. (c) The circRNA–miRNA–CDR1 coexpression network. CDR1: cerebellar degeneration‐related autoantigen 1; circRNAs: circular RNAs; GBM: glioblastoma multiforme; mRNAs: messenger RNAs [Color figure can be viewed at wileyonlinelibrary.com]

Using a Venn diagram, 22 common circRNAs were detected between the FindCirc group (85 circRNAs) and CIRC_FINDER group (41 circRNAs). Then, mRNAs matching the 22 circRNAs were identified through circBase (http://www.circbase.org/). By intersecting these mRNAs with the 2,437 differentially expressed mRNAs identified above, CDR1 was identified. To characterize miRNA–circRNA–CDR1 interactions, CircNet was used to search and predict CDR1 sponge miRNAs. Figure 1c shows 14 miRNAs were predicted to sponge CDR1, including hsa‐miR‐671‐5p, hsa‐miR‐149‐3p, hsa‐miR‐377‐5p, and hsa‐miR‐7106‐5p. Among these results, several miRNAs were predicted to target hsa_circ_0001946 as well as sponge CDR1, including miR‐671‐5p.

3.2. Circ_0001946 and CDR1 were expressed at low levels, and miR‐671‐5 was expressed at high levels in GBM cell lines

To validate the results of the RNA‐seq and differential analysis, we performed qRT‐PCR to determine the expression levels of circ_0001946, miR‐671‐5p, and CDR1 in the GBM cell lines and HM. The results showed that compared to the HM group, the GBM cell line groups had low expression of circ_0001946 and CDR1 and high expression of miR‐671‐5p (Figure 2a–c; p < 0.001), consistent with the bioinformatics analysis.

Figure 2.

Figure 2

Targeting relationships between miR‐671‐5p and circ_0001946 or CDR1. (a–c) The relative expression of circ_0001946, miR‐671‐5p, and CDR1 in glioma cells was detected by qRT‐PCR. (d, e) The binding sites between miR‐671‐5p and circ_0001946 or CDR1. A dual luciferase reporter gene assay was used to verify the potential relationships. Mean ± SD, **p < 0.01. CDR1: cerebellar degeneration‐related autoantigen 1; qRT‐PCR: quantitative real‐time PCR; SD: standard deviation

3.3. miR‐671‐5p interacted with circ_0001946 and CDR1

miR‐671‐5p binding sites were found in circ_0001946 in the CircInteractome analysis, and the result of the TargetScan ( http://www.targetscan.org/vert_71/ ) analysis suggested that CDR1 might be a target of miR‐671‐5p as well. A dual‐luciferase reporter gene assay was used to verify these potential relationships, and the relative luciferase activity was significantly decreased in the cells cotransfected with circ_0001946‐wt and the miR‐671‐5p mimics or CDR1‐wt and the miR‐671‐5p mimics compared with the cells cotransfected with circ_0001946‐wt and NC or CDR1‐wt and NC, respectively, (Figure 2d,e), which confirmed the predicted target relationships.

3.4. CDR1 expression was positively regulated by circ_0001946 and negatively regulated by miR‐671‐5p

We designed pcDNA3.1‐circ_0001946 and three siRNAs (si‐circ_0001946‐1, si‐circ_0001946‐2, and si‐circ_0001946‐3). QRT‐PCR was used to study their effects on the expression of circ_0001946, and the results showed that the circ_0001946‐expressing plasmid could increase the circ_0001946 RNA level significantly, whereas si‐circ_0001946‐3 had the best silencing effect on the circ_0001946 RNA level in the GBM cells and was used for the next experiment (Figure 3a; p < 0.01). In addition, the expression of miR‐671‐5p was upregulated in the miR‐671‐5p mimics group but downregulated in the miR‐671‐5p inhibitor group, indicating that the miR‐671‐5p mimics and inhibitor were highly functional in the GBM cells (Figure 3b; p < 0.01). In addition, the western blotting and qRT‐PCR results showed that CDR1 expression was significantly upregulated with the overexpression of circ_0001946, whereas the silencing of circ_0001946 markedly reduced CDR1 expression (Figure 3c,d; p < 0.01), suggesting that circ_0001946 positively regulated the expression of CDR1. In addition, the overexpression of miR‐671‐5p significantly suppressed CDR1 expression, which was upregulated when miR‐671‐5p was inhibited (Figure 3e,f; p < 0.01), indicating that the expression of CDR1 was negatively regulated by miR‐671‐5p.

Figure 3.

Figure 3

Si‐circ_0001946, the miR‐671‐5p mimics and the miR‐671‐5p inhibitor could affect the expression of circ_0001946 and miR‐671‐5p. (a) The influence of si‐circ_0001946‐1, si‐circ_0001946‐2, si‐circ_0001946‐3, and pcDNA3.1‐circ_0001946 on the expression of circ_0001946 in glioma cells was detected by qRT‐PCR. (b) The influence of the miR‐671‐5p mimics and miR‐671‐5p inhibitor on the expression of miR‐671‐5p was detected by qRT‐PCR. (c, d) Western blotting and qRT‐PCR were used to determine the impact of circ_0001946 and si‐circ_0001946 on the CDR1 expression level. (e, f) The effect of the miR‐671‐5p mimics and the miR‐671‐5p inhibitor on CDR1 expression was detected by western blotting and qRT‐PCR. Mean ± SD, **p < 0.01. CDR1: cerebellar degeneration‐related autoantigen 1; qRT‐PCR: quantitative real‐time PCR; SD: standard deviation

3.5. Circ_0001946 antagonized miR‐671‐5p to regulate GBM

To verify whether circ_0001946 and miR‐671‐5p can affect cell progression in GBM, we used a colony formation assay to determine their influence on cell colony formation, and the result showed circ_0001946 could suppress cell colony formation; however, miR‐671‐5p promoted colony formation. In addition, we found that circ_0001946 counteracted the effect of miR‐671‐5p (Figure 4a,b). A flow cytometry assay was used to measure cell apoptosis (Figure 4c,d), and transwell migration and invasion assays were performed to determine the migration and invasion of glioma cells (Figure 4e,h). The results showed that when circ_0001946 was overexpressed, the GBM cells displayed strong apoptosis and weakened proliferation, migration, and invasion, which was the opposite of the results observed with the overexpression of miR‐671‐5p. In addition, circ_0001946 could reduce the impact of miR‐671‐5p.

Figure 4.

Figure 4

Circ_0001946 suppressed glioma progression by regulating miR‐671‐5p. To investigate the relationship between circ_0001946 and miR‐671‐5p, we divided the cells into four groups: NC, circ_0001946, miR‐671‐5p mimics, and circ_0001946+miR‐671‐5p mimics. (a, b) A colony formation assay was used to assess cell proliferation. (c, d) Flow cytometry was performed to detect the apoptosis rate. The migration (e, f) and invasion (g, h) of glioma cells were determined by transwell assays, bar = 20 μm. Mean ± SD, **p < 0.01. SD: standard deviation [Color figure can be viewed at wileyonlinelibrary.com]

3.6. miR‐671‐5p had an inhibitory effect on CDR1

We verified a CDR1‐overexpressing cell line by qRT‐PCR (Figure 5a) and western blotting (Figure 5b,c) and then investigated the effects of CDR1 and CDR1+miR‐671‐5p in GBM. The experimental content included colony formation (Figure 6a,b), flow cytometry (Figure 6c,d) and transwell migration and invasion experiments (Figure 6e–g). The results indicated that CDR1 inhibited cell colony formation, migration, and invasion and promoted apoptosis, but miR‐145‐5p could inhibit the function of CDR1.

Figure 5.

Figure 5

Transfection efficiency of pcDNA3.1‐CDR1. The pcDNA3.1 vector was used to overexpress CDR1. The mRNA and protein levels of CDR1 were detected by qRT‐PCR and western blotting, respectively. CDR1: cerebellar degeneration‐related autoantigen 1; mRNA: messenger RNA; qRT‐PCR: quantitative real‐time PCR

Figure 6.

Figure 6

miR‐671‐5p can abolish the inhibitory effect of CDR1 on glioma cells. To investigate the relationship between CDR1 and miR‐671‐5p, we divided the cells into three groups: NC, CDR1, and CDR1+miR‐671‐5p. (a, b) A colony formation assay was used to assess cell proliferation. (c, d) Flow cytometry was performed to detect the apoptosis rate. The migration (e, f) and invasion (g, h) of glioma cells were determined by transwell assays, bar = 20 μm. Mean ± SD, **p < 0.01. CDR1: cerebellar degeneration‐related autoantigen 1; SD: standard deviation [Color figure can be viewed at wileyonlinelibrary.com]

3.7. Circ_0001946 inhibited glioma progression in a xenograft mouse model

The expression levels of circ_0001946, miR‐671‐5p, and CDR1 in vivo were detected by qRT‐PCR. The results indicated that the expression of circ_0001946 and CDR1 was promoted and that of miR‐671‐5p was suppressed in the tumor tissue compared with the adjacent nontumor tissue (Figure 7a,c). The RNA expression levels showed the correlations between circ_0001946/miR‐671‐5p/CDR1 as well. The correlation between circ_0001946 expression and CDR1 expression was positive, whereas the circ_0001946 and CDR1 levels were both negatively correlated with the miR‐671‐5p level (Figure 7d–f). The expression levels suggested that the regulation described above functioned not only in vitro but also in vivo.

Figure 7.

Figure 7

miR‐671‐5p had negative correlation between circ_0001946 and CDR1 in vivo. The RNA expression levels of circ_0001946 (a) miR‐671‐5p (b) and CDR1 (c) in the tumor isolated from the control group of mice. (d–f) The correlations of CDR1/miR‐671‐5p, miR‐671‐5p/circ_0001946, and CDR1/circ_0001946 which were based on the qRT‐PCR results. CDR1: cerebellar degeneration‐related autoantigen 1; qRT‐PCR: quantitative real‐time PCR

In addition, we established a xenograft ovarian cancer mouse model and examined the effects in the control, si‐circ_0001946, circ_0001946, circ_0001946+miR‐671‐5p, and circ_0001946+CDR1 groups on the tumor (Figure 8a). The results showed that the circ_0001946 group exhibited a significant increase in the survival time of the mice and a decrease in the volume and weight of tumors, and these results were even more obvious in the circ_0001946+CDR1 group (Figure 8b,c). However, the results from the circ_0001946+miR‐671‐5p group were basically identical to those of the control group. The immunohistochemistry results in the tumor tissue also indicated that circ_0001946 could significantly promote the expression of Ki67 and offset the effect of miR‐671‐5p (Figure 8d–e).

Figure 8.

Figure 8

Circ_0001946 inhibits glioma cells in vivo. (a) Survival curve was drawn based on experimental data. (b) Photographs of tumor xenografts 5 weeks after inoculation. (c) Tumor growth curves measured after injection of U87 cells stably transfected with control, si‐circ_0001946, circ_0001946, circ_0001946+miR‐671‐5p, and circ_0001946+CDR1. (d) The weight of the tumor is obtained by an electronic balance. (e) Immunohistochemistry was used to detect the expression of Ki67. Mean ± SD, **p < 0.01. CDR1: cerebellar degeneration‐related autoantigen 1; SD: standard deviation [Color figure can be viewed at wileyonlinelibrary.com]

4. DISCUSSION

In the present study, we determined that circ_0001946 was poorly expressed, whereas miR‐671‐5p was overexpressed in GBM. The relationships between miR‐671‐5p and circ_0001946/CDR1 were demonstrated through a chip analysis, qRT‐PCR and luciferase reporter gene experiments. The western blotting results showed that the expression of CDR1 was positively regulated by circ_0001946 but negatively regulated by miR‐671‐5p, indicating that circ_0001946 suppressed miR‐671‐5p to promote CDR1 expression. The cell function experiment found that the overexpression of circ_0001946 inhibited GBM cell migration, invasion, and proliferation, and this inhibition could be counteracted by inhibiting miR‐671‐5p. In addition, the immunohistochemistry results showed that circ_0001946 could significantly reduce the expression of Ki67 (a proliferation‐associated protein) in the mouse brain tissue, which also indicates that circ_0001946 can reduce the activity of GBM cells. Taken together, our results lead us to conclude that circ_0001946 targeted miR‐671‐5p to promote CDR1 expression and reduce GBM cell metastatic progression, identifying a molecular mechanism in GBM and suggesting a new potential therapeutic target.

Some researchers have illuminated regulatory roles for miR‐671 in the nervous system. Piwecka et al. (2017) revealed that in the human brain, the circRNA 0001946 is directly and strongly bound by miR‐671 in a way that impacts normal brain functions, such as sensorimotor gating and synaptic transmission. Nan et al. (2017) demonstrated that miR‐671 suppresses neuronal apoptosis by targeting the apoptosis‐associated factors Caspase 8 and p38. In response to lead‐induced neuronal toxicity, lncRpa and circRar1 can promote neuronal apoptosis via the regulation of miR‐671. It has been reported that miR‐671 is also involved in other cancers. Rutnam and Yang (2012) found that miR‐671 inhibited MDA‐MB‐231 breast cancer cell invasion and cell adhesion by binding to the 3′‐UTR of CD44, which promoted metastasis in breast cancer. In contrast, Yu et al. (2018) confirmed that miR‐671 promotes the proliferation of prostate cancer cells by inhibiting SOX6. In our experiment, the expression level of miR‐671‐5p was distinctly upregulated in the GBM cells. In addition, miR‐671‐5p was a direct negative regulator of CDR1 in the in vitro experiments.

CircRNAs are a large group of RNAs that exhibit the structural feature of covalently closed loops. They are found to be highly abundant, evolutionally conserved and relatively stable in the cytoplasm, contributing to numerous potential functions, such as serving as miRNA sponges, modulating gene transcription through binding to RNA‐associated proteins, and forming RNA–protein complexes (Li et al., 2015). Yang et al. (2018) found that circ‐FBXW7 encodes the functional protein FBXW7‐185aa in human cells; both circ‐FBXW7 and FBXW7‐185aa expression levels are low in glioblastoma patient samples. In addition, circ_FBXW7 expression has a positive relationship with overall survival in glioblastoma, suggesting potential prognostic significance for circ_FBXW7 in brain cancer. Zhu et al. (2017) identified a profile of dysregulated circRNAs in GBM such as circ_BRAF, which might be involved in tumor formation and GBM development and therefore could serve as a biomarker for pathological grade prediction and prognosis in patients with glioma. CDR1 antisense (CDR1as), a circRNA that acts as a miR‐7 sponge, is highly expressed in both the human and mouse brain, and strong suppression of miR‐7 activity increases the levels of miR‐7 targets. Overlapping coexpression between CDR1as and miR‐7 is observed in the mouse brain, particularly in neocortical and hippocampal neurons, implying a high degree of endogenous interaction (Hansen et al., 2013).

Expressed intensely in the cytoplasm of cerebellar Purkinje cells, CDR1 is encoded by the CDR34 gene. CDR34 is involved in neuronal and glial functions, and its upregulation is closely associated with the development of human neurodegenerative diseases affecting the cerebellum (Satoh & Yamamura, 2004). The downregulation of CDR1 expression might indeed cause the loss of differentiation of neural cells, leading to neoplastic transformation (Chen et al., 1990). As mentioned above, CDR1as is a circRNA obviously upregulated in the human brain as well as the mouse brain, and CRD1as is the only circRNA known to be targeted for degradation by a miRNA (miR‐671‐5p; Hansen et al., 2013). CDR1as expression is positively correlated with CDR1 expression, and both are suppressed by miR‐671‐5p; thereby, this network contributes to the malignancy of GBM (Hansen et al., 2011). In the present study, we detected the circRNA hsa_circ_0001946, which directly sponges miR‐671‐5p and positively regulates the expression of CDR1. The overexpression of hsa_circ_0001946 suppressed the migration, invasion, and proliferation of GBM cells, counteracting the protumorigenic effects of miR‐671‐5p.

The Ki67 nuclear proliferation antigen is an important immunohistochemical marker that has been reported in many studies (Wilkie, Fraser, & Raja, 2018); it appears in the middle or late G1 stage, and its expression increases through the S and G2 stages until it reaches a peak during the M stage (Endl & Gerdes, 2000). Ki67 is encoded by the Ki67 gene (Warth et al., 2014). It has been reported that Ki67 expression contributes to poor outcomes in many malignancies, including breast cancer (Calik et al., 2015) and prostate cancer (Tabata et al., 2014). In the present study, we performed immunohistochemical staining for Ki67, and the results showed that circ_0001946 expression could increase the percentage of Ki67+cells, and CDR1 expression increased this effect, whereas miR‐671‐5p canceled this effect. In addition, our study confirmed that the circ_0001946/miR‐671‐5p/CDR1 axis was involved in the progression of GBM, further elucidating the molecular mechanisms underlying GBM and identifying a new potential therapeutic target.

In fact, when a coexpression network analysis was conducted, the result (Pearson Correlation Coefficient > 0.7) showed that only CDR1 formed a complete circRNA–miRNA–mRNA axis, and we then verified the targeting of each axis by TargetScan (http://www.targetscan.org/vert_71/); the results showed that only miR‐671‐5p could target circ_0001946 and CDR1. In summary, the circ_0001946/miR‐671‐5p/CDR1 axis was chosen for our study.

Some studies have previously discussed the circ_0001946/miR‐671‐5p/CDR1 axis in GBM. Barbagallo et al. (2016) previously demonstrated the functional involvement of the miR‐671‐5p/CDR1AS/CDR1/VSNL1 axis in GBM, and Hansen et al. (2011) demonstrated how miR‐671‐5p may target CDR1AS and how this molecule may activate CDR1 transcription and further act as a miR‐7 sponge (Memczak et al., 2013). In addition, all these references, together with a recent literature review, describe the involvement of circRNAs in GBM (Barbagallo et al., 2018). However, our paper still has some differences from these studies. In our study, we used RNA‐seq and DESeq. 2 analysis to determine the differentially expressed genes (DEGs) and verified the target relationships between miR‐671‐5p and circ_0001946/CDR1 with a dual‐luciferase reporter assay. In addition, we conducted in vivo experiments which further illustrated the function of the circ_0001946/miR‐671‐5p/CDR1 axis in GBM in vivo.

In some ways, our experiments have some limitations. The clinical significance of circ_0001946 and miR‐671‐5p may need to be addressed in larger cohorts. Due to time constraints, we did not study the related downstream proteins of circ_0001946/miR‐671‐5p; therefore, more experiments are needed to clarify the mechanistic link between circ_0001946/miR‐671‐5p and the malignant progression of GBM. Furthermore, although a tumor suppressor role was identified, the use of circ_0001946 in clinical applications is still in the distant future.

Taken together, the results of our study demonstrated that circ_0001946 could sponge miR‐671‐5p and restrain GBM cell malignancy. More important, the activation of the circ_0001946/miR‐671‐5p/CDR1 axis may be a potential therapeutic target and contribute to the treatment of human GBM.

ETHICAL APPROVAL

All procedures performed in studies involving animals were in accordance with the ethical standards of Shengjing Hospital of China Medical University.

FUNDING

The study was supported by the project of “Mechanism of mir‐19a Regulating RTN1 Gene Affecting Autophagy of Glioma Stem Cells” of Liaoning Province Natural Science Funds (Grant Number: 201602840); “The Cross‐Talk Network of the Dysfunction Pathways Associated with Parkinson's Disease was Combined with Bioinformatics Analysis to Identify Biomarkers” of Liaoning Province Natural Science Funds (Grant Number: 201602818); “Silybin Induced Autophagy of Glioma Stem Cells to Play An Anti‐Tumor Molecular Mechanism” of Key Research and Development Project in Liaoning Province (Grant Number: 2018225094).

CONFLICTS OF INTEREST

The authors declare that they have no competing interests.

References

REFERENCES

  1. Barbagallo, D. , Caponnetto, A. , Cirnigliaro, M. , Brex, D. , Barbagallo, C. , D’angeli, F. , … Purrello, M. (2018). CircSMARCA5 inhibits migration of glioblastoma multiforme cells by regulating a molecular axis involving splicing factors SRSF1/SRSF3/PTB. International Journal of Molecular Sciences, 19(2). 10.3390/ijms19020480 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barbagallo, D. , Condorelli, A. , Ragusa, M. , Salito, L. , Sammito, M. , Banelli, B. , … Purrello, M. (2016). Dysregulated miR‐671‐5p/CDR1‐AS/CDR1/VSNL1 axis is involved in glioblastoma multiforme. Oncotarget, 7(4), 4746–4759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Çalik, M. , Demirci, E. , Altun, E. , Çalik, I. , Gündoğdu, Ö. B. , Gürsan, N. , … Albayrak, M. (2015). Clinicopathological importance of Ki‐67, p27, and p53 expression in gastric cancer. Turkish Journal of Medical Sciences, 45(1), 118–128. [DOI] [PubMed] [Google Scholar]
  4. Chen, Y. T. , Rettig, W. J. , Yenamandra, A. K. , Kozak, C. A. , Chaganti, R. S. , Posner, J. B. , & Old, L. J. (1990). Cerebellar degeneration‐related antigen: A highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse. Proceedings of the National Academy of Sciences of the United States of America, 87(8), 3077–3081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chung, H. J. , Choi, Y. E. , Kim, E. S. , Han, Y. H. , Park, M. J. , & Bae, I. H. (2015). miR‐29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2. Oncotarget, 6(21), 18429–18444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Endl, E. , & Gerdes, J. (2000). Posttranslational modifications of the KI‐67 protein coincide with two major checkpoints during mitosis. Journal of Cellular Physiology, 182(3), 371–380. [DOI] [PubMed] [Google Scholar]
  7. Hansen, T. B. , Jensen, T. I. , Clausen, B. H. , Bramsen, J. B. , Finsen, B. , Damgaard, C. K. , & Kjems, J. (2013). Natural RNA circles function as efficient microRNA sponges. Nature, 495(7441), 384–388. [DOI] [PubMed] [Google Scholar]
  8. Hansen, T. B. , Wiklund, E. D. , Bramsen, J. B. , Villadsen, S. B. , Statham, A. L. , Clark, S. J. , & Kjems, J. (2011). miRNA‐dependent gene silencing involving Ago2‐mediated cleavage of a circular antisense RNA. EMBO Journal, 30(21), 4414–4422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jeck, W. R. , & Sharpless, N. E. (2014). Detecting and characterizing circular RNAs. Nature Biotechnology, 32(5), 453–461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lasda, E. , & Parker, R. (2014). Circular RNAs: Diversity of form and function. RNA, 20(12), 1829–1842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Li, J. , Yang, J. , Zhou, P. , Le, Y. , Zhou, C. , Wang, S. , … Gong, Z. (2015). Circular RNAs in cancer: Novel insights into origins, properties, functions and implications. American Journal of Cancer Research, 5(2), 472–480. [PMC free article] [PubMed] [Google Scholar]
  12. Lien, G. S. , Liu, J. F. , Chien, M. H. , Hsu, W. T. , Chang, T. H. , Ku, C. C. , … Ho, J. H. (2014). The ability to suppress macrophage‐mediated inflammation in orbital fat stem cells is controlled by miR‐671‐5p. Stem Cell Research & Therapy, 5(4), 97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Maachani, U. B. , Tandle, A. , Shankavaram, U. , Kramp, T. , & Camphausen, K. A. (2016). Modulation of miR‐21 signaling by MPS1 in human glioblastoma. Oncotarget, 7(33), 52912–52927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Memczak, S. , Jens, M. , Elefsinioti, A. , Torti, F. , Krueger, J. , Rybak, A. , … Rajewsky, N. (2013). Circular RNAs are a large class of animal RNAs with regulatory potency. Nature, 495(7441), 333–338. [DOI] [PubMed] [Google Scholar]
  15. Nan, A. , Chen, L. , Zhang, N. , Liu, Z. , Yang, T. , Wang, Z. , … Jiang, Y. (2017). A novel regulatory network among LncRpa, CircRar1, MiR‐671 and apoptotic genes promotes lead‐induced neuronal cell apoptosis. Archives of Toxicology, 91(4), 1671–1684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Omuro, A. , & DeAngelis, L. M. (2013). Glioblastoma and other malignant gliomas: A clinical review. Journal of the American Medical Association, 310(17), 1842–1850. [DOI] [PubMed] [Google Scholar]
  17. Papp, G. , Krausz, T. , Stricker, T. P. , Szendrői, M. , & Sápi, Z. (2014). SMARCB1 expression in epithelioid sarcoma is regulated by miR‐206, miR‐381, and miR‐671‐5p on Both mRNA and protein levels. Genes, Chromosomes & Cancer, 53(2), 168–176. [DOI] [PubMed] [Google Scholar]
  18. Piwecka, M. , Glažar, P. , Hernandez‐Miranda, L. R. , Memczak, S. , Wolf, S. A. , Rybak‐Wolf, A. , … Rajewsky, N. (2017). Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science, 357(6357). 10.1126/science.aam8526 [DOI] [PubMed] [Google Scholar]
  19. Rutnam, Z. J. , & Yang, B. B. (2012). The non‐coding 3′ UTR of CD44 induces metastasis by regulating extracellular matrix functions. Journal of Cell Science, 125(Pt 8), 2075–2085. [DOI] [PubMed] [Google Scholar]
  20. Satoh, J. , & Yamamura, T. (2004). Gene expression profile following stable expression of the cellular prion protein. Cellular and Molecular Neurobiology, 24(6), 793–814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tabata, K. , Tanaka, T. , Hayashi, T. , Hori, T. , Nunomura, S. , Yonezawa, S. , & Fukuoka, J. (2014). Ki‐67 is a strong prognostic marker of non‐small cell lung cancer when tissue heterogeneity is considered. BMC Clinical Pathology, 14, 23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tan, X. , Fu, Y. , Chen, L. , Lee, W. , Lai, Y. , Rezaei, K. , … Fu, S. W. (2016). miR‐671‐5p inhibits epithelial‐to‐mesenchymal transition by downregulating FOXM1 expression in breast cancer. Oncotarget, 7(1), 293–307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wang, Z. , Yang, J. , Xu, G. , Wang, W. , Liu, C. , Yang, H. , … Wu, M. (2015). Targeting miR‐381‐NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors. Oncotarget, 6(5), 3147–3164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Warth, A. , Cortis, J. , Soltermann, A. , Meister, M. , Budczies, J. , Stenzinger, A. , … Weichert, W. (2014). Tumour cell proliferation (Ki‐67) in non‐small cell lung cancer: A critical reappraisal of its prognostic role. British Journal of Cancer, 111(6), 1222–1229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wilkie, M. D. , Fraser, H. M. , & Raja, H. (2018). Gaviscon(R) advance alone versus co‐prescription of Gaviscon(R) advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux. European Archives of Oto‐Rhino‐Laryngology, 275(10), 2515–2521. [DOI] [PubMed] [Google Scholar]
  26. Yang, Y. , Gao, X. , Zhang, M. , Yan, S. , Sun, C. , Xiao, F. , … Zhang, N. (2018). Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis. Journal of the National Cancer Institute, 110(3), 304–315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yu, Y. , Wang, Z. , Sun, D. , Zhou, X. , Wei, X. , Hou, W. , … Hou, Y. (2018). miR‐671 promotes prostate cancer cell proliferation by targeting tumor suppressor SOX6. European Journal of Pharmacology, 823, 65–71. [DOI] [PubMed] [Google Scholar]
  28. Zhu, J. , Ye, J. , Zhang, L. , Xia, L. , Hu, H. , Jiang, H. , … Luo, C. (2017). Differential expression of circular RNAs in glioblastoma multiforme and its correlation with prognosis. Translational Oncology, 10(2), 271–279. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cellular Physiology are provided here courtesy of Wiley

RESOURCES